title: Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?
authors.forename: M
authors.initials: M
authors.lastname: Ardine
authors.forename: D
authors.initials: D
authors.lastname: Generali
authors.forename: M
authors.initials: M
authors.lastname: Donadio
authors.forename: S
authors.initials: S
authors.lastname: Bonardi
authors.forename: M
authors.initials: M
authors.lastname: Scoletta
authors.forename: A M
authors.initials: AM
authors.lastname: Vandone
authors.forename: M
authors.initials: M
authors.lastname: Mozzati
authors.forename: O
authors.initials: O
authors.lastname: Bertetto
authors.forename: A
authors.initials: A
authors.lastname: Bottini
authors.forename: L
authors.initials: L
authors.lastname: Dogliotti
authors.forename: A
authors.initials: A
authors.lastname: Berruti
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology*; D002118:Calcium / Q000097:blood / Q000633:toxicity*; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced*; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced*; D010281:Parathyroid Hormone / Q000097:blood / Q000633:toxicity*
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D010281:Parathyroid Hormone; D002118:Calcium